Fundamental Analysis Stories

PCOM
  over six months ago at Macroaxis 
By Ellen Johnson
Points Intl is scheduled to announce its earnings tomorrow. Communication services space may be getting hot again, let's check if Points Intl is sending any bullish signals to investors. We will evaluate why recent Points Intl price moves suggest a bounce in September. Points Intl probability of financial unrest is under 1 percent. Will the firm stakeholders continue to acquire in September?
DRNA
  over six months ago at Macroaxis 
By Ellen Johnson
Dicerna Pharmaceutic Revenue Per Employee is projected to increase significantly based on the last few years of reporting. The past year's Revenue Per Employee was at 542,576. The current year Average Assets is expected to grow to about 782.4 M, whereas Net Income Per Employee is forecasted to decline to (401.7 K). Despite somewhat strong basic indicators, Dicerna Pharmaceutic is not utilizing all of its potentials. The current stock price disturbance, may contribute to a short-term swings for the investors. We currently estimate Dicerna Pharmaceutic as undervalued. The real value is approaching 34.43 per share.
III
  over six months ago at Macroaxis 
By Ellen Johnson
Information Svcs Earnings Before Interest Taxes and Depreciation Amortization EBITDA are most likely to increase significantly in the upcoming years. The last year's value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA was reported at 15.4 Million. The current Earnings before Tax is estimated to increase to about 7.6 M, while Average Assets are projected to decrease to roughly 187.5 M. Information Svcs is scheduled to announce its earnings tomorrow. The upcoming quarterly report is expected on the 9th of August 2021. While some of us are excited about technology space, let's try to concentrate on Information Svcs Group in greater detail to make a better evaluation of its fundamental indicators. The company follows the market closely. We can now examine Information as a potential investment option for your portfolios.
CEVA
  over six months ago at Macroaxis 
By Gabriel Shpitalnik
Ceva Revenue Per Employee is projected to decrease significantly based on the last few years of reporting. The past year's Revenue Per Employee was at 247,653. The current year Earnings Before Interest Taxes and Depreciation Amortization EBITDA is expected to grow to about 9.5 M, whereas Net Income Per Employee is forecasted to decline to (6 K). If you have been following Ceva you may be considering taking in. Let's check if strong basic indicators will continue to push the price to rise for Ceva's investors. The company current chance of distress is under 1 percent. Will investors continue to be optimistic, or should we expect a sell-off?
VUZI
  over six months ago at Macroaxis 
By Raphi Shpitalnik
If you have been keeping an eye on Vuzix Corp you know that now may not be the best time to buy. Vuzix Corp current chance of financial distress is over 55%. Are Vuzix Corp stockholders still optimistic?
MIT
  over six months ago at Macroaxis 
By Raphi Shpitalnik
In spite of rather sound technical and fundamental indicators, MITCHELLS BUTLERS is not utilizing all of its potentials. The new stock price tumult, may contribute to a shorter-term swings for the shareholders. MITCHELLS BUTLERS PLC moves totally opposite to the market. We can now discuss MITCHELLS as a potential investment option for your portfolios.
APD
  over six months ago at Macroaxis 
By Gabriel Shpitalnik
In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. The entity current odds of distress is under 11 percent. Will shareholders continue to be optimistic, or should we expect a sell-off?
IMPL
  over six months ago at Macroaxis 
By Rifka Kats
The upcoming quarterly report is expected on the 6th of September 2021. The stock continues to experience an active upward rally. Is healthcare space attracting new stakeholders, let's check if Impel Neuropharma is sending any bullish signals. We will look into reasons why it is still very possible for the company to generate above-average returns. Impel Neuropharma responds to the market. We can now summarize Impel as a potential investment option for your portfolios.
BYSI
  over six months ago at Macroaxis 
By Gabriel Shpitalnik
Despite nearly weak basic indicators, Beyondspring reported solid returns over the last few months and may actually be approaching a breakup point. Beyondspring probability of bankruptcy is under 41 percent. Will Beyondspring stockholders continue to buy in September?
WPRT
  over six months ago at Macroaxis 
By Raphi Shpitalnik
The stock is currently undergoing an active upward rally. Many investors are getting excited about consumer cyclical space, let's analyze if Westport Fuel Systems fundamentals are strong enough to attract traders. We will evaluate if Westport Fuel shares are reasonably priced going into September. Westport Fuel Systems current probability of distress is over 82%. Are Westport Fuel Systems private investors still optimistic?